Internal Medicine, Interventional Cardiology · Memphis, TN
NPI
1841277308
Since 2005
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
6799 Great Oaks Rd
Memphis, TN, 38138
Phone (901) 751-0405
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
22,709 services
Medicare patients, 2024
2,200
Average age 76
Drug cost, 2024
$1.9M
15,975 prescriptions
Company payments, 2025
$1,021
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohamed Bashar A Shala was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 4,350 times for 43 patients. In total Mohamed Bashar A Shala billed 22,709 services in 123 codes, and Medicare paid $1.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-02-14.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 4,350 | 43 | $0.10 | $419 |
| 99214 Office E&M - Established | Office | 3,349 | 1,875 | $85.42 | $286K |
| 93000 Electrocardiogram | Office | 3,077 | 1,927 | $9.33 | $29K |
| 93306 Echocardiography (TTE/TEE) | Office | 1,697 | 1,608 | $120.72 | $205K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 1,649 | 410 | $4.46 | $7,355 |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 989 | 556 | $88.82 | $88K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 773 | 617 | $12.11 | $9,358 |
| 99213 Office E&M - Established | Office | 700 | 577 | $55.59 | $39K |
| 93015 Electrocardiogram | Office | 616 | 596 | $45.19 | $28K |
| 78452 Myocardial Perfusion Scan | Office | 575 | 571 | $302.66 | $174K |
| 36415 Venipuncture Blood Collection | Office | 392 | 338 | $8.58 | $3,365 |
| 85025 Blood Count | Office | 325 | 292 | $7.59 | $2,468 |
| 99204 Office E&M - New | Office | 316 | 316 | $105.20 | $33K |
| 83735 Clinical Chemistry | Office | 306 | 273 | $6.55 | $2,006 |
| 80061 Clinical Chemistry | Office | 287 | 260 | $13.04 | $3,742 |
By year: 2022 $1.0M for 20,102 services; 2023 $1.1M for 21,409 services; 2024 $1.1M for 22,709 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 392 | 338 | $8.58 | $3,365 |
| 85025 Blood Count | 325 | 292 | $7.59 | $2,468 |
| 83735 Clinical Chemistry | 306 | 273 | $6.55 | $2,006 |
| 80061 Clinical Chemistry | 287 | 260 | $13.04 | $3,742 |
| 82550 Clinical Chemistry | 275 | 250 | $6.35 | $1,745 |
| 80053 Clinical Chemistry | 271 | 248 | $10.32 | $2,797 |
| 84439 Clinical Chemistry | 232 | 214 | $8.81 | $2,045 |
| 84443 Clinical Chemistry | 231 | 213 | $16.46 | $3,802 |
| 85610 Clinical Chemistry | 93 | 18 | $4.20 | $391 |
| 80048 Clinical Chemistry | 85 | 78 | $8.29 | $705 |
Medicare prescription drug claims, 2024
In 2024, the drug Mohamed Bashar A Shala prescribed most often to Medicare patients was Metoprolol Succinate, with 1,298 prescriptions and refills. In total Mohamed Bashar A Shala wrote 15,975 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,298 | 2,992 | 393 | $14K |
| Eliquis Apixaban | 1,070 | 1,635 | 233 | $916K |
| Rosuvastatin Calcium Generic | 1,054 | 2,721 | 354 | $14K |
| Amlodipine Besylate Generic | 946 | 2,400 | 326 | $5,840 |
| Atorvastatin Calcium Generic | 844 | 2,182 | 285 | $7,676 |
| Carvedilol Generic | 714 | 1,731 | 225 | $5,753 |
| Losartan Potassium Generic | 669 | 1,640 | 224 | $7,135 |
| Clopidogrel Clopidogrel Bisulfate | 623 | 1,526 | 185 | $5,463 |
| Metoprolol Tartrate Generic | 622 | 1,502 | 219 | $3,495 |
| Furosemide Generic | 481 | 1,067 | 181 | $2,370 |
| Sotalol Sotalol Hcl | 461 | 1,092 | 128 | $7,237 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 386 | 942 | 139 | $6,053 |
| Amiodarone Hcl Generic | 377 | 841 | 130 | $6,447 |
| Olmesartan-Hydrochlorothiazide Olmesartan/Hydrochlorothiazide | 349 | 867 | 109 | $14K |
| Potassium Chloride Generic | 328 | 721 | 115 | $5,365 |
Brand drugs: 2,130 claims; generic drugs: 13,845 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohamed Bashar A Shala $1,021 ($1,021 in general payments such as food, travel and fees) from 15 companies. The largest payer was Medtronic, Inc. with $246.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 12 | $246 |
| Pfizer Inc. PFE | 11 | $210 |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $120 |
| Actelion Pharmaceuticals US, Inc. JNJ | 6 | $103 |
| Philips North America LLC PHG | 6 | $98.12 |
| Tactile Systems Technology Inc TCMD | 1 | $54.65 |
| Cordis US Corp. JNJ | 1 | $34.11 |
| Amgen Inc. AMGN | 2 | $30.83 |
| Boston Scientific Corporation BSX | 1 | $25.86 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $22.34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.